From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature neuroscience 2002-11, Vol.5 Suppl (11s), p.1027-1029
Hauptverfasser:	Heemskerk, Jill, Tobin, Allan J, Ravina, Bernard
Format:	Artikel
Sprache:	eng
Schlagworte:	Amyotrophic lateral sclerosis Animals Clinical trials Clinical Trials as Topic - adverse effects Clinical Trials as Topic - ethics Clinical Trials as Topic - trends Degeneration Disease Disease Models, Animal Dosage and administration Drug Design Drug Evaluation - ethics Drug Evaluation - trends Drug Evaluation, Preclinical - ethics Drug Evaluation, Preclinical - trends Drugs Ethics FDA approval Humans Laboratories Nervous system Nervous system agents Neurodegeneration Neurodegenerative Diseases - drug therapy Neurosciences Pharmaceutical industry Predictive Value of Tests Product/Service Evaluations Risk Assessment - ethics Risk Assessment - standards
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!